Fred Alger Management, LLC Eye Point Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $15,892 - $27,860	-2,192 Reduced 3.04%	69,908 $550,000
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $957,428 - $1.56 Million	-110,430 Reduced 60.5%	72,100 $876,000
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $627,261 - $1.13 Million	61,617 Added 50.96%	182,530 $2.23 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $908,056 - $1.42 Million	120,913 New	120,913 $1.26 Million

176

53.9M

764K

1.57M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $296M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.